First Medicine: It will undertake the procurement of anti-epidemic materials and is expected to generate revenue of 600 million to 800 million yuan

Post date April 8, 2022 — 00:10 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

Shanghai to resume business and market in phases starting today

May 16, 2022 — 04:45

In 2021, 70% of listed companies’ securities investment will be profitable: 233 companies earn more than 100 million yuan, but 196 companies withdraw – yqqlm

May 13, 2022 — 21:44

Shanghai Fengxian opens first batch of offline supermarkets

May 7, 2022 — 10:37

Shanghai pushes again a package of relief policies to help enterprises to resume work

May 5, 2022 — 07:41

Shanghai Stock Exchange Main Board Companies Are Actively Resuming Work and Production: Orders and Industrial Chains Are Most Concerned

April 26, 2022 — 23:13

First Pharmaceutical (600833): Shanghai First Pharmaceutical Co., Ltd. Announcement of Operating Data for the First Quarter of 2022- CFi.CN Zhongcai Network

April 23, 2022 — 20:55

Shanghai: In this round of epidemic, Chinese-funded state-owned enterprises acted quickly to ensure that the city's heart beats vigorously News Channel Hexun.com

April 22, 2022 — 15:21

The Shanghai Index rose 1.22% to recover 3,200 points, and the coal and brewing sectors rose sharply – yqqlm

April 14, 2022 — 15:46

Live: Hang Seng Index rose 0.411%-

April 14, 2022 — 09:55

Home » News » First Medicine: It will undertake the procurement of anti-epidemic materials and is expected to generate revenue of 600 million to 800 million yuan

Key Data Concepts: ? These are the company names, stock quotes, topics, and entities related to this data.